Veradigm amends 8-K to disclose consulting deal with ex-interim CFO Westerfield
Allscripts Healthcare Solutions, Inc. MDRX | 0.00 |
- Veradigm amended a March 31, 2026 Form 8-K to disclose a consulting agreement with former interim CFO Leland Westerfield.
- Deal signed May 26, 2026; effective June 1, 2026; Wilcox Capital to provide strategic financial advisory services through March 31, 2027.
- Monthly consulting fee set at $45,937.50 for 10 months; last two payments contingent on a signed, non-revoked general release.
- Restricted stock units valued at $100,000 to be granted after filing its annual report for fiscal 2023 and 2024; vesting set for March 31, 2027.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradigm Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-239471), on May 26, 2026, and is solely responsible for the information contained therein.
